Cervical cancer screening

-Automatic translation

HIV infected women

• Can follow the same age criteria for screening as HIV-negative women.

• Annual screening according to screening guidelines for different ages.

• If screening samples have always been negative and a woman is on adequate antiviral therapy, it is possible to consider stopping follow-up at the age of 65.

• In case of abnormal samples during screening, the follow-up is the same as for HIV-negative.

• Women who have needed treatment for a precancerous lesion need annual monitoring throughout their lives.

Organ recipients and stem cell recipients

• Can follow screening guidelines for different ages.

• No need for closer follow-up if screening samples are normal.

• It is important to inform about the increased risk of precancerous lesions.

• In case of abnormal samples during screening, the follow-up is the same as for healthy women.

• Follow-up throughout their lives.

Immunosuppressed women (e.g. due to immunosuppressive drugs for rheumatic disease, inflammatory disease)

• There is no reason for increased monitoring.

• Able to follow standard screening guidelines.